Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 167
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does sleep deprivation impact problematic eating?

Research studies have linked characteristics of eating disorders (e.g., binge eating, extreme dieting) with...

NoAAC Longitudinal Registry of Treatment Outcomes in iSGS

Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...

Developing a new treatment for Ebola Virus Disease

Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

Backer Badge Funded